Tech Company Financing Transactions
Vital Therapies Funding Round
Vital Therapies, based in San Diego, raised $16 million from private investors.
Transaction Overview
Company Name
Announced On
9/28/2012
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The San Diego-based company plans to use the capital to run Phase III clinical trials of a product that combines liver cells with a medical device that could help people with acute liver failure.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
15010 Ave. of Science 200
San Diego, CA 92128
USA
San Diego, CA 92128
USA
Phone
Website
Email Address
Overview
Vital Therapies, Inc. (NASDAQ: VTL) is a new company formed in 2003 to continue the development of the ELAD (Extracorporeal Liver Assist Device) System, which augments the metabolic functions of a patient's liver, thereby enabling a bridge to transplant or liver recovery. VTI acquired the assets and business of VitaGen/Hepatix.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Russell Cox
Chief Financial Officer
Michael Swanson
Chief Technical Officer
Robert Ashley
President
Duane Nash
Browse more venture capital transactions:
Prev: 9/28/2012: ChowNow venture capital transaction
Next: 9/28/2012: RAMP venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs